144 related articles for article (PubMed ID: 32737929)
21. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.
Jolivalt CG; Hurford R; Lee CA; Dumaop W; Rockenstein E; Masliah E
Exp Neurol; 2010 Jun; 223(2):422-31. PubMed ID: 19931251
[TBL] [Abstract][Full Text] [Related]
22. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
Tapia-Rojas C; Inestrosa NC
J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
[TBL] [Abstract][Full Text] [Related]
23. Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice.
Hayashi-Park E; Ozment BN; Griffith CM; Zhang H; Patrylo PR; Rose GM
Behav Brain Res; 2017 Mar; 322(Pt B):280-287. PubMed ID: 27173425
[TBL] [Abstract][Full Text] [Related]
24. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
25. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
26. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
28. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus.
Ren T; Liu J; Ge Y; Zhuo R; Peng L; Liu F; Jin X; Yang L
Neurochem Int; 2019 Oct; 129():104501. PubMed ID: 31299417
[TBL] [Abstract][Full Text] [Related]
29. Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.
Cassano V; Leo A; Tallarico M; Nesci V; Cimellaro A; Fiorentino TV; Citraro R; Hribal ML; De Sarro G; Perticone F; Sesti G; Russo E; Sciacqua A
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32023991
[No Abstract] [Full Text] [Related]
30. Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway.
FangFang ; Li H; Qin T; Li M; Ma S
Metab Brain Dis; 2017 Apr; 32(2):385-393. PubMed ID: 27761760
[TBL] [Abstract][Full Text] [Related]
31. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
Anderson M; Xu F; Ou-Yang MH; Davis J; Van Nostrand WE; Robinson JK
J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989
[TBL] [Abstract][Full Text] [Related]
32. Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice.
Oliveira WH; Braga CF; Lós DB; Araújo SMR; França MR; Duarte-Silva E; Rodrigues GB; Rocha SWS; Peixoto CA
Exp Brain Res; 2021 Sep; 239(9):2821-2839. PubMed ID: 34283253
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.
Liu LP; Yan TH; Jiang LY; Hu W; Hu M; Wang C; Zhang Q; Long Y; Wang JQ; Li YQ; Hu M; Hong H
Acta Pharmacol Sin; 2013 Apr; 34(4):455-63. PubMed ID: 23524568
[TBL] [Abstract][Full Text] [Related]
34. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
35. Effects of analog P165 of amyloid precursor protein 5-mer peptide on learning, memory and brain insulin receptors in the rat model of cognitive decline.
Xu BL; Wang R; Meng XH; Zhao ZW; Wang HJ; Ma LN; Dong W; Sheng SL; Ji ZJ
Neurol Sci; 2014 Nov; 35(11):1821-6. PubMed ID: 24946940
[TBL] [Abstract][Full Text] [Related]
36. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
37. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
[TBL] [Abstract][Full Text] [Related]
38. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.
Ramos-Rodriguez JJ; Infante-Garcia C; Galindo-Gonzalez L; Garcia-Molina Y; Lechuga-Sancho A; Garcia-Alloza M
Mol Neurobiol; 2016 May; 53(4):2685-97. PubMed ID: 26156287
[TBL] [Abstract][Full Text] [Related]
39. Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.
Kang X; Wang D; Zhang L; Huang T; Liu S; Feng X; Guo Y; Zhang Z; Wang Z; Ren H; Yuan G
Mol Med; 2023 Sep; 29(1):118. PubMed ID: 37667187
[TBL] [Abstract][Full Text] [Related]
40. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
